0 CHECKOUT

Anthrax - Pipeline Review, H2 2015

  • ID: 3455149
  • September 2015
  • 160 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • Aduro BioTech, Inc.
  • Aradigm Corporation
  • ContraFect Corporation
  • Grifols, S.A.
  • Microbiotix, Inc.
  • PaxVax
  • MORE

Anthrax - Pipeline Review, H2 2015

Summary

The report ‘Anthrax - Pipeline Review, H2 2015’, provides an overview of the Anthrax’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Anthrax, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anthrax and special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updates following a stringent set of processes that ensures that all the profiles are updated with the READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Aduro BioTech, Inc.
  • Aradigm Corporation
  • ContraFect Corporation
  • Grifols, S.A.
  • Microbiotix, Inc.
  • PaxVax
  • MORE

List of Tables

List of Figures

Introduction

REPORT COVERAGE

Anthrax Overview

Therapeutics Development

Pipeline Products for Anthrax - Overview

Pipeline Products for Anthrax - Comparative Analysis

Anthrax - Therapeutics under Development by Companies

Anthrax - Therapeutics under Investigation by Universities/Institutes

Anthrax - Pipeline Products Glance

Late Stage Products

Clinical Stage Products

Early Stage Products

Anthrax - Products under Development by Companies

Anthrax - Products under Investigation by Universities/Institutes

Anthrax - Companies Involved in Therapeutics Development

Aduro BioTech, Inc.

Altimmune, Inc.

Aphios Corporation

Aradigm Corporation

Bavarian Nordic A/S

Bristol-Myers Squibb Company

Cellceutix Corporation

ContraFect Corporation

Dynavax Technologies Corporation

Elusys Therapeutics, Inc.

Emergent BioSolutions Inc.

Green Cross Corporation

Grifols, S.A.

Hawaii Biotech, Inc.

iBio, Inc.

Innovative Biologics, Inc.

Microbiotix, Inc.

NanoBio Corporation

Oragenics, Inc.

PaxVax

Pfenex Inc.

PharmAthene, Inc.

Protein Potential, LLC

ProThera Biologics, LLC.

PsiOxus Therapeutics Limited

Soligenix, Inc.

Syntiron LLC

Tetraphase Pharmaceuticals Inc.

United Therapeutics Corporation

VLP Biotech, Inc.

Anthrax - Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Combination Products

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Drug Profiles

anthrax + plague vaccine - Drug Profile

anthrax vaccine - Drug Profile

anthrax vaccine - Drug Profile

anthrax vaccine - Drug Profile

anthrax vaccine - Drug Profile

anthrax vaccine - Drug Profile

anthrax vaccine - Drug Profile

anthrax vaccine - Drug Profile

anthrax vaccine - Drug Profile

anthrax vaccine - Drug Profile

anthrax vaccine next generation - Drug Profile

anthrax virus like particle vaccine - Drug Profile

ARD-3100 - Drug Profile

AV-7909 - Drug Profile

CF-306 - Drug Profile

CF-307 - Drug Profile

CF-308 - Drug Profile

ciprofloxacin hydrochloride - Drug Profile

DPX-Anthrax - Drug Profile

DV-230 - Drug Profile

Epimerox - Drug Profile

GC-1109 - Drug Profile

GREANX - Drug Profile

Human Antibody Based Vaccines - Drug Profile

KKL-35 - Drug Profile

Marinus - Drug Profile

MDX-1303 - Drug Profile

Monoclonal Antibody for Respiratory Anthrax - Drug Profile

Monoclonal Antibody to Inhibit Anthrax Protective Antigen for Anthrax - Drug Profile

MU-1140 - Drug Profile

MVA-BN Anthrax - Drug Profile

obiltoxaximab - Drug Profile

PBI-220 - Drug Profile

Peptides to Disrupt Cell Membrane for Infectious Diseases - Drug Profile

PMX-0196 - Drug Profile

PMX-0231 - Drug Profile

PMX-0243 - Drug Profile

PMX-225 - Drug Profile

PreviThrax - Drug Profile

Proteins to Inhibit Furin for Anthrax Intoxication and Sepsis - Drug Profile

Px-563L - Drug Profile

RC-100b - Drug Profile

RiVax + SGX-204 - Drug Profile

Second Generation Px-563L - Drug Profile

SGX-204 - Drug Profile

Small Molecule to Inhibit Anthrax Toxin and Alpha Hemolysin for Anthrax and Staphylococcal aureus Pneumonia - Drug Profile

Small Molecule to Inhibit DNA Helicase for Infectious Diseases - Drug Profile

Small Molecule to Inhibit Enoyl-Reductase for Bacillus Anthracis and Francisella Tularensis Infections - Drug Profile

Small Molecules for Bacterial Infections - Drug Profile

Small Molecules to Inhibit Anthrax Lethal Factor Toxin for Anthrax - Drug Profile

Small Molecules to Inhibit Lethal Factor for Anthrax - Drug Profile

Small Molecules to Inhibit Lethal Factor for Anthrax and Cystic Fibrosis - Drug Profile

Synthetic Peptides for Bacterial Infections - Drug Profile

TP-271 - Drug Profile

Anthrax - Recent Pipeline Updates

Anthrax - Dormant Projects

Anthrax - Discontinued Products

Anthrax - Product Development Milestones

Featured News & Press Releases

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Number of Products under Development for Anthrax, H2 2015

Number of Products under Development for Anthrax - Comparative Analysis, H2 2015

Number of Products under Development by Companies, H2 2015

Number of Products under Investigation by Universities/Institutes, H2 2015

Comparative Analysis by Late Stage Development, H2 2015

Comparative Analysis by Clinical Stage Development, H2 2015

Comparative Analysis by Early Stage Development, H2 2015

Products under Development by Companies, H2 2015

Products under Development by Companies, H2 2015 (Contd..1)

Products under Development by Companies, H2 2015 (Contd..2)

Products under Investigation by Universities/Institutes, H2 2015

Anthrax - Pipeline by Aduro BioTech, Inc., H2 2015

Anthrax - Pipeline by Altimmune, Inc., H2 2015

Anthrax - Pipeline by Aphios Corporation, H2 2015

Anthrax - Pipeline by Aradigm Corporation, H2 2015

Anthrax - Pipeline by Bavarian Nordic A/S, H2 2015

Anthrax - Pipeline by Bristol-Myers Squibb Company, H2 2015

Anthrax - Pipeline by Cellceutix Corporation, H2 2015

Anthrax - Pipeline by ContraFect Corporation, H2 2015

Anthrax - Pipeline by Dynavax Technologies Corporation, H2 2015

Anthrax - Pipeline by Elusys Therapeutics, Inc., H2 2015

Anthrax - Pipeline by Emergent BioSolutions Inc., H2 2015

Anthrax - Pipeline by Green Cross Corporation, H2 2015

Anthrax - Pipeline by Grifols, S.A., H2 2015

Anthrax - Pipeline by Hawaii Biotech, Inc., H2 2015

Anthrax - Pipeline by iBio, Inc., H2 2015

Anthrax - Pipeline by Innovative Biologics, Inc., H2 2015

Anthrax - Pipeline by Microbiotix, Inc., H2 2015

Anthrax - Pipeline by NanoBio Corporation, H2 2015

Anthrax - Pipeline by Oragenics, Inc., H2 2015

Anthrax - Pipeline by PaxVax, H2 2015

Anthrax - Pipeline by Pfenex Inc., H2 2015

Anthrax - Pipeline by PharmAthene, Inc., H2 2015

Anthrax - Pipeline by Protein Potential, LLC, H2 2015

Anthrax - Pipeline by ProThera Biologics, LLC., H2 2015

Anthrax - Pipeline by PsiOxus Therapeutics Limited, H2 2015

Anthrax - Pipeline by Soligenix, Inc., H2 2015

Anthrax - Pipeline by Syntiron LLC, H2 2015

Anthrax - Pipeline by Tetraphase Pharmaceuticals Inc., H2 2015

Anthrax - Pipeline by United Therapeutics Corporation, H2 2015

Anthrax - Pipeline by VLP Biotech, Inc., H2 2015

Assessment by Monotherapy Products, H2 2015

Assessment by Combination Products, H2 2015

Number of Products by Stage and Target, H2 2015

Number of Products by Stage and Mechanism of Action, H2 2015

Number of Products by Stage and Route of Administration, H2 2015

Number of Products by Stage and Molecule Type, H2 2015

Anthrax Therapeutics - Recent Pipeline Updates, H2 2015

Anthrax - Dormant Projects, H2 2015

Anthrax - Dormant Projects (Contd..1), H2 2015

Anthrax - Dormant Projects (Contd..2), H2 2015

Anthrax - Dormant Projects (Contd..3), H2 2015

Anthrax - Discontinued Products, H2 2015

List of Figures

Number of Products under Development for Anthrax, H2 2015

Number of Products under Development for Anthrax - Comparative Analysis, H2 2015

Number of Products under Development by Companies, H2 2015

Number of Products under Investigation by Universities/Institutes, H2 2015

Comparative Analysis by Clinical Stage Development, H2 2015

Comparative Analysis by Early Stage Products, H2 2015

Assessment by Monotherapy Products, H2 2015

Number of Products by Top 10 Targets, H2 2015

Number of Products by Stage and Top 10 Targets, H2 2015

Number of Products by Top 10 Mechanism of Actions, H2 2015

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015

Number of Products by Top 10 Routes of Administration, H2 2015

Number of Products by Stage and Top 10 Routes of Administration, H2 2015

Number of Products by Top 10 Molecule Types, H2 2015

Number of Products by Stage and Top 10 Molecule Types, H2 2015

Note: Product cover images may vary from those shown
3 of 4

Aduro BioTech, Inc.
Altimmune, Inc.
Aphios Corporation
Aradigm Corporation
Bavarian Nordic A/S
Bristol-Myers Squibb Company
Cellceutix Corporation
ContraFect Corporation
Dynavax Technologies Corporation
Elusys Therapeutics, Inc.
Emergent BioSolutions Inc.
Green Cross Corporation
Grifols, S.A.
Hawaii Biotech, Inc.
iBio, Inc.
Innovative Biologics, Inc.
Microbiotix, Inc.
NanoBio Corporation
Oragenics, Inc.
PaxVax
Pfenex Inc.
PharmAthene, Inc.
Protein Potential, LLC
ProThera Biologics, LLC.
PsiOxus Therapeutics Limited
Soligenix, Inc.
Syntiron LLC
Tetraphase Pharmaceuticals Inc.
United Therapeutics Corporation
VLP Biotech, Inc.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Genentech, Inc.
  • GlaxoSmithKline PLC
  • Maquet Getinge Group
  • Emergent BioSolutions, Inc.
  • Aicuris GmbH & Co.KG
  • Merck & Co., Inc.